← Eichor
Condition: Cystic Fibrosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cystic Fibrosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

BASE: Bronchiectasis Severity and Exacerbation Risk Study
Phase N/A · 1 location(s) · Assiut University · NCT07599839A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled R
Phase 1 · 1 location(s) · Revagenix, Inc. · NCT07709494Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Phase N/A · 18 location(s) · Jaeb Center for Health Research · NCT06837181Breathing Training and Exercise Capacity in Non-CFB
NA · 1 location(s) · Mayo Clinic · NCT05860803Physical Impairments in Children With Cystic Fibrosis
Phase N/A · 1 location(s) · Izmir Democracy University · NCT06984679Kidney Function in People With Cystic Fibrosis in the Era of HEMT
Phase N/A · 3 location(s) · University of Virginia · NCT06595420Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic F
Phase N/A · 1 location(s) · Ospedale San Raffaele · NCT06413459Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
Phase 2 · 3 location(s) · SpliSense Ltd. · NCT06429176Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
Phase N/A · 1 location(s) · Medical College of Wisconsin · NCT06560463Remote Sputum Collection in Cystic Fibrosis
Phase N/A · 3 location(s) · University of Pennsylvania · NCT06950892Estrogen Supplementation and Bone Health in Women With CF
Phase 4 · 1 location(s) · Johns Hopkins University · NCT05704036Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Pat
Phase N/A · 4 location(s) · Charite University, Berlin, Germany · NCT04732910Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Phase 2 · 1 location(s) · University of Kansas Medical Center · NCT06364176Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Phase N/A · 18 location(s) · University of Pittsburgh · NCT06296394Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure
Phase N/A · 2 location(s) · Research Center Borstel · NCT07369414Autogenic Drainage Versus Mechanical Percussion in Children With Cystic Fibrosis
NA · 1 location(s) · Riphah International University · NCT07729787Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis
Phase N/A · 2 location(s) · Gelb, Arthur F., M.D. · NCT03839992Regional Phenotyping of CF and Non-CF Bronchiectasis
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT04793867Markers of Osteoporosis in Cystic Fibrosis
Phase 4 · 1 location(s) · University of Texas Southwestern Medical Center · NCT03921060A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Phase 2 · 51 location(s) · Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahw · NCT06559150FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Phase 2 · 2 location(s) · University of Pennsylvania · NCT04731272A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF
Phase 2 · 3 location(s) · Heidelberg University · NCT03925194A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Phase 3 · 2 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT06660992Maralixibat in Patients With Cystic Fibrosis and Constipation
Phase 2/Phase 3 · 1 location(s) · Children's Hospital Los Angeles · NCT06413368A Study to Access Activity and Safety With SAR445399 Compared With Placebo in Participants Aged 18 to 80 Years of Age Wi
Phase 2 · 4 location(s) · Sanofi · NCT07547436Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
Phase N/A · 6 location(s) · Alexander Horsley · NCT07484607Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2
Phase 1 · 2 location(s) · Sionna Therapeutics Inc. · NCT07035990Phase 2 Study to Assess the Safety and Efficacy of ANG003
Phase 2 · 26 location(s) · Anagram Therapeutics, Inc. · NCT07450547
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.